Your browser doesn't support javascript.
loading
Impact of Botulinum Toxin Injections on Quality of Life of Patients with Long-Standing Peripheral Facial Palsy.
Amar, Jérémy; Tankere, Frédéric; Picard, Diane; Alciato, Lauranne; Carré, Fabienne; Foirest, Claire.
Afiliação
  • Amar J; ENT Department, Pitié Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France.
  • Tankere F; ENT Department, Pitié Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France.
  • Picard D; ENT Department, Pitié Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France.
  • Alciato L; ENT Department, Pitié Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France.
  • Carré F; ENT Department, Pitié Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France.
  • Foirest C; ENT Department, Pitié Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France.
Toxins (Basel) ; 16(3)2024 Mar 08.
Article em En | MEDLINE | ID: mdl-38535806
ABSTRACT
(1)

Background:

Sequels of facial palsy lead to major psychosocial repercussions, disrupting patients' quality of life (QoL). Botulinum toxin (BoNT) injections can permit us to treat long-standing facial palsy, improving facial symmetry and functional signs including synkinesis and contractures. (2)

Methods:

The main aim of this study was to assess the evolution of the QoL for patients with long-standing facial palsy before, at 1 month, and at 4 months after BoNT injections by using three questionnaires (HFS-30, FaCE, and HAD). The other goals were to find clinical factors associated with the improvement in the QoL and to assess the HFS-30 questionnaire for patients with unilateral facial palsy (3)

Results:

Eighty-eight patients were included in this study. There was a statistically significant improvement in QoL at 1 month after injections, assessed using the three questionnaires. This improvement was sustained at 4 months after the injections, with a statistically significant difference for the HFS-30 and FaCE questionnaires. (4)

Conclusions:

This study showed that the BoNT injections lead to a significant increase in the QoL of patients with unilateral facial palsy. This improvement is sustained 4 months after the injections.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas / Paralisia de Bell / Paralisia Facial Limite: Humans Idioma: En Revista: Toxins (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas / Paralisia de Bell / Paralisia Facial Limite: Humans Idioma: En Revista: Toxins (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França